STAT spoke with people living through the historic disruptions threatening the future of biomedical research in the U.S.

A spokesperson said Thursday that "NIH initially exceeded its internal targets for contract reductions" in explaining the ...

The NIH has scaled back its awards of new grants by at least $2.3 billion since the beginning of the year, a STAT analysis ...

The company is hoping longer follow-up will deliver enough positive trial data on its CRISPR T-cell therapies for blood ...

Health Secretary Robert F. Kennedy Jr. spoke at a large meeting of addiction experts, encountering both cheers and repeated ...

STAT is tracking, day by day, what's happened in the words of science and health during the first months of the Trump ...

STAT's Adam Feuerstein puts all his “Biotech Doom Loop” panic-mongering aside, as he embraces luminescent moonbeams and downy ...

A former FDA commissioner and a former Institute of Medicine president are teaming up to create the Vaccine Integrity Project ...

More than a dozen states are seeking federal permission to add work requirements to their Medicaid programs. Three states — ...

A new study on Lyme disease sheds light on the persistence of symptoms; another new study points to an antibiotic that may be ...

In today's Pharmalittle roundup, we're reading about Roche and Merck struggles with tariffs, NEJM quizzed by U.S. attorney, ...

STAT reporters chat about pharma tariffs, the latest recovery in biotech stocks, and disappointing data from a Bristol Myers ...